Articles and Videos
BTV Interview with InMed CEO, Eric Adams Full Version
InMed Biosynthesis Platform – Potential to Produce High Quality Pharmaceutical-Grade Cannabinoids Efficiently
InMed is a biopharmaceutical company that specializes in the discovery and development of novel, cannabinoid-based therapeutics for the treatment of diseases with high unmet medical...
Eric A. Adams talks with BTV about InMed’s biosynthesis of cannabinoids
In this video, InMed CEO Eric A. Adams speaks with BTV about InMed's focus on cannabinoid-based pharmaceutical products. Mr. Adams talks about the company's proprietary...